HUMORAL IMMUNE RESPONSE IN CROSS-BRED HEIFERS IMMUNIZED WITH BRUCELLA ABORTUS STRAIN RB51 VACCINE IN MILITARY DAIRY FARM OF BANGLADESH

Author:

Rahman M. M.,Rahman M. S.,Rahman A. K. M. A.,Maruf A. A.,Hossain M. M.,Rana M. S.,Neubauer H

Abstract

Background: Brucellosis is a chronic zoonotic disease with negligible mortality rate that might be the reason not to attract the concerned authority to prevent and eradicate it in low income endemic countries. Recently, it has been recognized as a re-emerging zoonotic disease not only in low income countries but also its eradicated developed world. Objective: The main objective was to determine the humoral immune response (HIR) in crossbred dairy heifers immunized with Brucella abortus strain RB51 vaccine by using indirect ELISA Materials and Methods: Each of the 20 randomly selected B. abortus sero-negative crossbred (Holstein-Friesian  Local) dairy heifers aged between 4 to 8 months old at the Military Dairy Farm received 2.0 ml imported commercial B. abortus SRB51 strain vaccine subcutaneously in the neck region at day 0 and then booster dose at 60 days after first vaccination with similar dose and route during the period from June to October 2020. Each of the collected serum samples of 20 heifers at day 0, 7, 14, 21, 28, 60, 90, 120 and 150 was tested to detect the antibody status by using commercial indirect ELISA kit. Results: The humoral immune response (HIR) in terms of antibody levels detected by OD values in the serum of immunized cross-bred dairy heifers by using B. abortus strain RB51 commercial vaccine resulted 0.097  0.0032 (mean  SE) OD value at 0 day (i.e. pre-immunization) and 0.108 ± 0.0032 at 7th day. After that, the OD value started to rise from day 14 (OD value 0.124 ± 0.0032) and reached to a peak level at 60 days (OD value 0.223  0.0032) with the initial vaccination. Booster vaccination inoculated at 60 days resulted peak antibody level in terms of OD value (0.313  0.0032) at the day 90 and then the antibody level started to decline from 120 days (OD value 0.242  0.0032) to 150 days (OD value 0.199 0.0032) in cross-bred dairy heifers. Conclusions: This study suggests that the commercial B. abortus RB51 strain vaccine has induced satisfactory HIR with initial inoculation and significantly higher HIR produced with a booster dose in crossbred heifers by using commercial I-ELISA. The presence of Brucella antibodies have importance on sero-diagnosis whereas the cell mediated immunity (CMI) plays major role in protection against brucellosis which needs further investigation in cross-bred heifers in Bangladesh. Keywords: Brucellosis, SRB51 vaccine, Humoral immune response, I-ELISA, Cross-bred heifers, Bangladesh

Publisher

Bangladesh Society for Veterinary Medicine

Reference39 articles.

1. Corbel MJ (2006). Brucellosis in Humans and Animals. Geneva: World Health Organization. who.int/csr/resources/publications/Brucellosis.pdf

2. OIE (2019). Infection with Brucellaabortus, Brucellamelitensis and Brucellasuis. Chapter 8.4.Terrestrial Animal Health Code- 28/06/2019. oie.int/fileadmin/Home/eng/Health_standards/tahc/ current/chapitre_bovine_brucellosis.pdf

3. Olsen S and Palmer M (2014).Advancement of knowledge of Brucella over the past 50 years. Veterinary Pathology 51: 1076-1089.

4. Ghanbari MK, Gorji HA, Behzadifar M, Sanee N, Mehedi N and Bragazzi L (2020). One health approach to tackle brucellosis: a systematic review. Tropical Medicine and Health 48, 86 (2020). [doi: 10.1186/s41182-020-00272-1]

5. Pal M, Gizaw F, Fekadu G, Alemayehu G and Kandi V (2017). Public health and economic importance of bovine brucellosis: an review. American Journal of Epidemiology 5: 27-34

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3